TLR4 and myeloid sarcoma: For example, kolaviron- (Omotoso et al., 2020) and auraptene (Arabi et al., 2021) supplementation reduced MS- induced increases in glial fibrillary protein, and TLR-4 and Il-1β expression, respectively.